Health Care Policy in a Post Pandemic World

To be held virtually on Thursday, November 18th, 9:00 am – 11:30 am

Keynote Speaker

Dr. Ezekiel Emanuel, MD

Vice Provost for Global Initiatives, Diane v.S. Levy and Robert M. Levy University Professor, and Co-Director of the Healthcare Transformation Institute University of Pennsylvania

Dr. Ezekiel Emanuel, MD, is one of the leading practitioners shaping the future of health care, with a long record of experience at the top levels of policy. Trained both as an oncologist (MD, Harvard Medical School) and a political scientist, Zeke offers a uniquely thoughtful perspective on the most difficult issues in medicine today. From 2009 to 2011, Zeke was a special advisor for health policy to the White House Office of Management and Budget. As one of the most prominent voices advising the White House about health care, he had a significant impact on federal health care budgets and the Affordable Care Act. Dr. Emanuel is the Vice Provost for Global Initiatives, and the Diane v.S. Levy and Robert M. Levy University Professor at the University of Pennsylvania. He is a founding chair at the Clinical Center of the National Institutes of Health. Dr. Emanuel is also a Special Advisor to the Director General of the World Health Organization (WHO). He is the author of 15 books including, Reinventing American Health Care and Prescription for the Future. Dr. Emanuel published two new books in 2020. The first, co-authored with Abbe Gluck, evaluates the Affordable Care Act ten years after the landmark legislation and is titled The Trillion Dollar Experiment (March 2020), and the other is Which Country Has the Best Health Care in the World? (June 2020), an examination of ten health care systems across the globe, in search of the best. Dr. Emanuel will share his perspective on the Biden Administration’s impact on health care policy in Massachusetts and throughout the U.S. Please click here for full bio.

Full agenda to follow

Novo Nordisk makes innovative medicines to help people with diabetes manage their disease. The company’s ultimate goal is to defeat diabetes through prevention, detection and better management, and empower people with diabetes to live longer, healthier lives.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.

Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions

Preti Strategies is an elite team of former lawmakers and experienced leaders in government relations, public affairs and communications. With offices in Massachusetts and New Hampshire, they have worked with clients to achieve goals nationwide.

Alkermes is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases.

Delta Dental serves more than 80 million Americans, providing groups and individuals with quality, cost-effective dental insurance and superior customer service.

MedImpact is the PBM that puts clients and consumers first. For 30 years, they have had a single mission: To help make pharmacy benefits affordable, understandable, and honest.

Reliable Respiratory is one of the leading independently owned home respiratory and specialty medical equipment providers in the U.S., providing equipment and service to patients throughout New England.

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.